DABRAFENIB FOR RESISTANT BRAF MUTATED MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS

被引：0
|
作者：
Hays, Julia Allyson [1 ,2 ]
机构：
[1] Childrens Mercy Hosp, Kansas City, MO 64108 USA
[2] Univ Missouri, Kansas City, MO 64110 USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [1] Langerhans Cell Histiocytosis in adults with Multi-system Involvement
    Mikhaimer, Nadia C.
    Egberts, Friederike
    Hauschild, Axel
    Schwarz, Thomas
    Kaehler, Katharina C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (09): : 679 - 679
  • [2] Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosis
    Whitlock, James A.
    Geoerger, Birgit
    Dunkel, Ira J.
    Roughton, Michael
    Choi, Jeea
    Osterloh, Lisa
    Russo, Mark
    Hargrave, Darren
    BLOOD ADVANCES, 2023, 7 (15) : 3806 - 3815
  • [3] Langerhans cell histiocytosis presenting as a multi-system disorder in an infant
    Hu, Sheng
    Wang, Wenging
    Wang, Chen
    Ma, Rui
    Xiao, Zhaoyang
    Dong, Hailong
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2012, 51 (06) : 709 - 712
  • [4] REACTIVATION AND SEQUELAE IN MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS AT A SINGLE INSTITUTION
    Braier, Jorge
    Rosso, Diego
    Chantada, Guillermo
    Latella, Antonio
    Balancini, Blanca
    Bernaldez, Patricia
    Vaiani, Elisa
    Goldberg, Julio
    PEDIATRIC BLOOD & CANCER, 2011, 56 (04) : 691 - 691
  • [5] Impact of reactivation on the sequelae of multi-system Langerhans cell histiocytosis patients
    Morimoto, Akira
    Kobayashi, Ryoji
    Maeda, Miho
    Asami, Keiko
    Bessho, Fumio
    Imashuku, Shinsaku
    PEDIATRIC BLOOD & CANCER, 2008, 50 (04) : 931 - 932
  • [6] Remission of Congenital Multi-system Type Langerhans Cell Histiocytosis with Chemotherapy
    Tamefusa, Kosuke
    Ishida, Hisashi
    Washio, Kana
    Ishida, Toshiaki
    Morita, Hirosuke
    Shimada, Akira
    ACTA MEDICA OKAYAMA, 2019, 73 (01) : 61 - 65
  • [7] MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS PRESENTS AS BLUEBERRY MUFFIN RASH
    Fabrizio, V.
    Menghani, H.
    Velez, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 550 - 550
  • [8] Impact of reactivation on the sequelae of multi-system Langerhans cell histiocytosis patients - Response
    Pollono, Daniel
    Rey, Guadalupe
    Latella, Antonio
    Rosso, Diego
    Chantada, Guillermo
    Braier, Jorge
    PEDIATRIC BLOOD & CANCER, 2008, 50 (04) : 932 - 932
  • [9] CALCIFIED SPLENIC LESIONS IN A CHILD WITH CONGENITAL MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS
    Deurloo, Eline
    van den Bos, Cor
    Ahout, Inge
    Loza, Bettina
    Koot, Bart
    van Rijn, Rick
    PEDIATRIC BLOOD & CANCER, 2009, 53 (04) : 689 - 689
  • [10] INTENSIFIED AND PROLONGED THERAPY IMPROVED THE OUTCOME IN MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS
    Morimoto, Akira
    Shioda, Yoko
    Imamura, Toshihiko
    Kudo, Kazuko
    Sato, Takashi
    Shiohara, Masaaki
    Yasui, Masahiro
    Koga, Yuhki
    Kobayashi, Ryoji
    Ishii, Eiichi
    Fujimoto, Junichiro
    Horibe, Keizo
    Bessho, Fumio
    Tsunematsu, Yukiko
    Imashuku, Shinsaku
    PEDIATRIC BLOOD & CANCER, 2013, 60 (09) : E80 - E81
12345